Search results
We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do. We believe that a vertically integrated approach, from cell line development through fill and finish manufacturing, gives us the control, scale and speed needed to achieve our mission.
Alvotech. Better Access. Better Lives. We are led by science, driven by passion, and committed to biosimilars. We are continually evaluating additional pipeline opportunities to bring a strategic and robust selection of treatment options to patients around the world.
It is our aim to broaden the availability and accessibility of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars.
Alvotech is a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities.
Jun 7, 2024 · REYKJAVIK, Iceland, June 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the successful arrangement of a strategic refinancing transaction. The financing, led by GoldenTree Asset Management, with ...
Jun 15, 2022 · Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the U.S., Europe, Japan, China, and other Asian...
Jul 22, 2024 · BAD VILBEL, Germany and REYKJAVIK, Iceland, July 22, 2024 (GLOBE NEWSWIRE) -- STADA and Alvotech have launched Uzpruvo ®, the first approved biosimilar to Stelara ® in Europe, across a majority ...
Guidelines for Alvotech applicants. Available positions at Alvotech are posted on our Career page and applications must be made via our online recruitment system. Applications should be submitted in English.
Alvotech | 28,186 followers on LinkedIn. Better Access. Better Lives. | Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the ...
Jul 2, 2024 · Alvotech. Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® (denosumab) Two additional studies comparing the pharmacokinetics, safety, and...
